Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 253-981-4 | CAS number: 38517-37-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Different tests were done in order to assess genetic toxicity.
All were negative.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
In vitro:
A study was conducted to determine the in vitro genetic toxicity according to OECD Guideline 471 and EU Method B.13/14, in compliance with GLP. Dose range finding tests as well as direct plate and pre-incubation assays both in the absence and presence of S9-mix were performed. Salmonella typhimurium strains TA1535, TA1537, TA100 and TA98 and Escherichia coli strain WP2uvrA were exposed to the test substance at concentration levels of 0.55, 1.7, 5.4, 17, 52, 164, 512, 1600 and 5000 µg/plate, and also exposed to the negative or positive control substances for 48 ± 4 h (plus a pre-incubation time of 30 min if needed). In the dose range finding study, the test substance was initially tested up to 5000 µg/plate in the tester strains TA100 and WP2uvrA through a direct plate assay. The test substance showed precipitation at the highest dose level. Cytotoxicity was evidenced in TA100 in the absence and presence of S9 -mix. In tester strain WP2uvrA, no toxicity was observed at any of the dose levels tested. In the first mutation experiment, the test substance was tested up to concentrations of 1600 and 5000 µg/plate in the absence and presence of S9-mix, respectively in the tester strains TA1535, TA1537 and TA98. The test substance precipitated on the plates at the dose level of 5000 μg/plate. Cytotoxicity was observed in all tester strains in the absence and presence of S9-mix. Since the test substance was severely cytotoxic in the first mutation experiment, an additional dose range finding test was performed with strains TA100 and WP2uvrA, both with and without S9-mix according to the pre-incubation method. In this dose range finding study, the test substance was initially tested up to concentrations of 512 and 5000 µg/plate in the tester strains TA100 and WP2uvrA, respectively. The test substance precipitated at dose levels of 1600 and 5000 μg/plate and therefore the number of revertants of this dose level could not be determined. Cytotoxicity was observed in tester strain TA100 in the absence and presence of S9-mix. In tester strain WP2uvrA, no toxicity was observed up to the dose level of 1600 μg/plate. In the second mutation experiment, the test substance was tested up to concentrations of 164 and 512 µg/plate (in absence and presence of S9-mix, respectively) in the tester strains TA1535, TA1537 and TA98 in the pre-incubation assay. Cytotoxicity was observed in all three tester strains in the absence and presence of S9-mix. The test substance did not induce a significant dose-related increase in the number of revertant (His+) colonies in any of the four tester strains (TA1535, TA1537, TA98 and TA100) and in the number of revertant (Trp+) colonies in tester strain WP2uvrA both in the absence and presence of S9-metabolic activation. These results were confirmed in an independently repeated experiment. The negative and strain-specific positive control values were within the laboratory historical control data ranges indicating that the test conditions were adequate and that the metabolic activation system functioned properly. Under the study conditions, the substance was not mutagenic in the Salmonella typhimurium and Escherichia coli reverse mutation assay (Verspeek-Rip, 2006).
A study was conducted to determine the in vitro genetic toxicity of the read-across substance L-glutamic acid, N-coco acyl derivs., monosodium salts according to OECD Guideline 471, in compliance with GLP. Salmonella typhimurium strains TA1535, TA1537, TA98 and TA100 were exposed to the test substance at concentration levels of 0, 4, 20, 100, 500, 2500 and 5000 µg/plate with and without metabolic activation (S9-mix induced Aroclor 1254), and to negative or positive control substances for 48 h. In the dose range finding study, the test substance proved to be toxic for the bacterial strain TA 100 in the absence of a metabolizing system at a dose of 5000 µg/plate. Therefore 5000 µg/plate was chosen as the highest dose in the experiment. The test substance did not precipitate on the plates up to the highest investigated doses. The test substance did not induce toxicity or an increase in number of revertants at any concentration level. Under the study conditions, the substance was not mutagenic in S. typhimurium with and without metabolic activation (Hoechst, 1994).
A study was conducted to determine the in vitro genetic toxicity of the read-across substance L-glutamic acid, N-coco acyl derivs., disodium salts according to OECD Guideline 487, in compliance with GLP. Two independent experiments were performed in Chinese hamster lung fibroblasts (V79 cells). Cells were exposed to the test substance (diluted in water) at concentrations from 0 to 1600 µg/mL for either 4 or 24 h with and without metabolic activation (S9 mix).Cytotoxicity, indicated by a clearly reduced proliferation index, cell numbers or a low quality of the slides was observed in the absence of S9 mix at 700 µg/mL (1st experiment) and at 800 µg/mL (2nd and 3rd experiment). In the presence of S9 mix, cytotoxic effects were obtained 800 µg/mL onwards but only in the 2nd experiment. In the 1st experiment a single statistically significant increase in the number of micronucleated cells was observed at 700 µg/mL after 4 h exposure in the absence of metabolic activation. However, this finding was neither confirmed in the repeat experiment under similar conditions (3rd experiment) nor in any additional experiment under modified test conditions (24 h exposure in the absence of metabolic activation or 4 h exposure in the presence of metabolic activation). The finding was considered artifactual due to the strong cytotoxicity in this test group (RICC 41.4%). Under the study conditions, the substance was not clastogenic in Chinese hamster lung fibroblast V79 cells (BASF SE, 2013).
A study was conducted to determine the in vitro genetic toxicity of the read-across substance L-glutamic acid, N-coco acyl derivs., disodium salts according to OECD Guideline 476, in compliance with GLP. The potential to induce gene mutations at the hypoxanthine-guanine phosphoribosyl transferase (HPRT) locus was evaluated in Chinese hamster ovary (CHO) cells in vitro. Three independent experiments were carried out, with and without the addition of liver S9 mix from phenobarbital- and β- naphthoflavone induced rats (exogenous metabolic activation). In initial range-finding cytotoxicity test(s), the experimental doses of the main experiments were determined. Cells were exposed for 4 or 24 h to the test substance at concentrations from 0 to 1500 µg/mL. Vehicle and positive controls (ethyl methanesulphonate and 7,12 -dimethylbenzanthracene) were included as well in the experiments. The vehicle control showed mutation frequencies within the range expected for the CHO cell line. Both positive control substances led to the expected increase in the frequencies of forward mutations. In the 1st experiment in the absence and presence of metabolic activation and in the 2nd experiment in the presence of metabolic activation, the highest concentrations tested for gene mutations were clearly cytotoxic. However, in the 2nd experiment in the absence of metabolic activation no cytotoxicity was observed up to the highest applied concentration. Therefore, a 3rd experiment was performed which clearly showed reduced colony numbers at least at the highest concentrations. The test substance did not cause any relevant increase in the mutation frequency either without S9 mix or after the addition of a metabolizing system in the experiments. Under the study conditions, the substance was not mutagenic at the HPRT locus of Chinese hamster ovary cells (BASF SE, 2012).
Justification for classification or non-classification
Based on in vitro genetic toxicity studies with the substance itself and with the read-across substances L-glutamic acid, N-coco acyl derivs., monosodium salts and L-glutamic acid, N-coco acyl derivs., disodium salts, no classification for genetic toxicity is warranted according to EU CLP (1272/2008) criteria.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.